ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Clinton Names Broadnax HHS Deputy, Others to Sub-Cabinet Posts

March 5, 1993

Schmidt’s Doubts Threaten Control Saturation Program

August 22, 1975

GAO Offers Two Suggestions For Plant Screening

April 4, 1980

Lasagna Committee Urges Medicare Payment for Experimental Drugs, Care

September 29, 1989

NCI Recruiting Senior Scientist To Lead AIDS research

May 17, 1996

NCI Cooperative Group, Cancer Center Trials Listed

October 26, 2007